1-(4-Bromophenyl)-2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethan-1-one

Catalog No. :
ACIVNK897
CAS No. :
327978-80-3
Molecular Formula :
C14H9BrN2O3S
Molecular Weight :
365.21

IUPAC Name:1-(4-bromophenyl)-2-((5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)thio)ethan-1-one

1-(4-Bromophenyl)-2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$291.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromophenyl)-2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethan-1-one
IUPAC Name1-(4-bromophenyl)-2-((5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)thio)ethan-1-one
MDL No.MFCD01816671
Molecular FormulaC14H9BrN2O3S
Molecular Weight365.21
SMILESO=C(C1=CC=C(Br)C=C1)CSC2=NN=C(C3=CC=CO3)O2
InChI KeySHNZYJZYBYMAJE-UHFFFAOYSA-N
Synonym1-(4-BROMOPHENYL)-2-([5-(2-FURYL)-1,3,4-OXADIAZOL-2-YL]SULFANYL)-1-ETHANONE;1-(4-bromophenyl)-2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethan-1-one;Ethanone, 1-(4-bromophenyl)-2-[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]-
CAS No.327978-80-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIVNK897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVNK897 route product structure diagram
    ACIVNK897327978-80-3
Inquiry

2. ACIVNK897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVNK897 route product structure diagram
    ACIVNK897327978-80-3
Inquiry

Comments (0)